Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RH5.1/AS01 vaccine for blood-stage malaria
NCT02927145Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Oct 2016
- Primary completion
- Jun 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of RH5.1 + AS01 in malaria, sponsored by University of Oxford. Started Oct 2016; status: completed.
02
Drugs
RH5.1 + AS01
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02927145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02927145.